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While it is generally accepted that most B lymphocytes express Fe-receptors
(FcR) (1), 1 evidence for the expression ofFcR byT cells is controversial . Thus,
while some works have claimed that a high proportion of thymus cells display
FcR (2), others have failed to demonstrate FcR on these cells (1) . FcR, however,
could be detected on several murine T cell lymphomas (2, 3, andfootnote 2), and
several groups have reported FcR on T cells activated by H-2-determinants in
vivo (H-2-ATC) (2, 4) . This might suggest, therefore, that T cells express FcR
only at certain stages of differentiation .
The present paper reports that although a proportion of H-2-ATC recovered
from spleen displayed FcR, those recovered from thoracic duct lymph (T.TDL)
wereFcR negative . The same observation has been made forT cellsactivated by
M-locus determinants . In addition, Ia-antigens were found on ATC (spleen) and
T.TDL . These findings are discussed in relation to T-cell differentiation .
Materials and Methods
Animals .
￿
AKR/J, CBA/J (H-2", Mlsd), C3H/J (H-2', Mlse), SJL/J (H-2s), and F, hybrid mice
between CBA/J and C57BL/6 (C57BL) (H-2 b, Mlsb) and between SJL/J and C57BL/6 were used .
Cell Suspensions . Single cell suspensions were prepared from thymus, lymph node, and
spleen by teasing the tissue through a 60-mesh stainless steel screen into cold tissue culture (TC)
Medium 199 (Difco Laboratories, Detroit, Mich .) plus 10% fetal calfserum (FCS) (Flow Laborato-
ries, Rockville, Md.) and gently pipetting the cells through a 1-ml pipette . Cells were washed three
* Present address : I.C .R.F . Tumour Immunology Unit, Department of Zoology, University
College, London, WC1 6BT .
'Abbreviations used in this paper:ATC, activatedT cells; H-2-ATC, allogeneically- activated T
cells ; CFTD, complement fixation test diluent ; Con A, concanavalin A ; CRL, lymphocytes forming
complement rosettes ; CRT, cortisone-resistant thymocytes ; E-rosette, erythrocyte rosette ;
EA(IgG), ORBC sensitized with IgG anti-ORBC serum; EA(IgM), ORBC sensitized with IgM anti-
ORBC serum ; FCS, fetal calf serum ; FDA, fluorescein diacetate ; FcR, Fc-receptors ; GPC, guinea
pig complement; Thy 1.2, theta C3H ; MC, mouse (AKR/J serum) complement ; MIgG, EA rosettes
with ORBC sensitized with DBA anti-ORBC ; MIgM, EA rosettes with ORBC sensitized with
mouse anti-ORBC IgM ; ORBC, ox (bovine) red blood cells ; PBS, phosphate-buffered saline ; PHA,
phytohemagglutinin ; RC, rabbit C ; RIgG, EA rosettes with ORBC sensitized with serum 224 ;
RIgM, EA rosettes with ORBC sensitized with rabbit anti-ORBC IgM ; TC, tissue culture ; TDL,
thoracic duct lymphocytes ; T.TDL, thoracic duct T cells activated by GvH reaction . s Krammer, P . H ., R . Citronbaum, S . E . Read, L . Forni, and R . Lang . 1975 . Murine thymic
lymphomas as model tumors for T cell studies . T cell markers, immunoglobulin, and Fe-receptors
on AKR thymomas . Cell Immunol . In press .
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times in cold medium, and clumps were removed by letting the cell suspension settle for 5 min .
Viability of cells in the supernatant fluid was determined by trypan blue dye exclusion .
Thoracic duct lymphocytes (TDL) were collected as previously described (5) . T cells activated to
H-2-determinants were prepared by injecting 2 x 10 8 CBA thymus cells intravenously into X-
irradiated (800R) (CBA/J x C57BL)F, hybrid mice . The activated cells were then obtained 4-6
days later either from the spleen (ATC-spleen) or from thoracic duct lymph (T.TDL) (5) . In some
experiments, lymph node cells were used to prepare the ATC . ATC-spleen (SJL/J) were prepared
by injection of 5 x 108 nylon wool column purified SJL/J lymph node T cells into X-irradiated
(800 R) (SJIJJ x C57BL)F, hybrid mice . To obtain T cells activated by M-locus determinants,
C3H/J thymus cells were transferred into irradiated CBA/J mice .
Dead cells were removed from ATC-spleen by the method of v . Boehmer et al . (6), and
lymphocytes were isolated over a Ficoll gradient (recovery of viable ATC-spleen was 30-40%) .
Suspensions of thymus cells were depleted ofB cells by filtration through Sephadex G-100 columns
conjugated with rabbit antimouse Ig antibody (7) . In other experiments lymph node cells were
freed ofB cells by passage through nylon wool columns (8) . The relative proportions ofT and B
cells in each population was determined by indirect immunofluorescence and cytotoxicity with
anti-Thy 1 .2 (theta C3H) serum . These methods have been described elsewhere (9,10) .
For preparation of cortisone resistant thymocytes, (CRT) mice were injected with 0.125 mg
hydrocortisoneacetate/g and the thymus removed 2 days later . Normal thymocytes or CRT were
stimulated by concanavalin A (Con A) or phytohemagglutinin (PHA) . Stimulation ofcultured cells
wasmeasured by incorporation of [3H]thymidine as describedelsewhere (11) . 5gg ConAand 10 Ag
PHA were optimal for stimulation. Stimulation indices were : normal thymus cells Con A 196,
PHA 5 ; CRT ConA 230, PHA 30 .
Antisera .
￿
Anti-Thy 1.2 serumwas raised by the method of Raff(12) . Anti-C57, anti-CBA, and
anti-SJL sera were produced in CBA, C57, and C3H, respectively, as described previously (13) .
These sera were specific for their targets . The preparation and specificity ofATH anti-ATL serum
has extensively been described elsewhere (14) .
Fc- and C-Receptors .
￿
A rosette test with relatively nonagglutinable bovine erythrocytes (ox
(bovine) red blood cells, ORBC) as indicator cells was used to detect FcR (EA rosettes) and C-
receptors (EAC rosettes) .
Rabbit (gift from Dr . M. Ferrarini, Genova) as well as mouse (DBA) anti-ORBC sera were
prepared . Rabbit-anti-ORBC serum 224 (rich in IgG), rabbit-anti-ORBC (IgM) (purified IgM
fraction in a dilution of 1 :50 in complement fixation test diluent [CFTD]), and Balb/cManti-ORBC
serum (Sephadex G-200column purified IgM) were used for sensitization of indicator cells . Neither
Balb/cM anti-ORBC IgM nor DBA anti-ORBC serum showed any agglutination of ORBC, al-
though the hemolytic titer (with guinea pigcomplement [GPC1 diluted 1:10) was 1:64 for Balb/cM
anti-ORBC (IgM) and 1 :1,024 for DBA anti-ORBC serum . For sensitization of ORBC, Balb/cM
anti-ORBC IgM was diluted 1:2 or 1 :4 in CFTD, and DBA anti-ORBC serum was diluted 1:5 in
phosphate-buffered saline (PBS) .
Preparation ofSensitized Red Cells for EA-Rosettes .
￿
Equalvolumes of a 2% ORBC suspension
inPBSand either rabbit or mouseanti-ORBC antisera (serum 224 or DBAanti-ORBC antiserum),
at the dilutions indicated above, were incubated for 30 min at room temperature . After incubation,
thered cells were washed twice in PBS andresuspended to 0.5% (vol/vol) inTC Medium 199 plus
10% FCS (modified from [151) .
Preparation of Sensitized Red Cells for EAC-Rosettes .
￿
ORBC, thoroughly washed in CFTD
(16), were sensitized as above with the indicated dilutions of either rabbit anti-ORBC IgM or
Balb/cM anti-ORBC IgM, and washed twice in CFTD . The EA complex was then treated with
mouse complement (AKR serum previously absorbed at 4°C for 30 min with an equal volume of
washed, packed ORBC and diluted 1:2 in CFTD), washed twice in CFTD, and adjusted to a
concentration of 0.5% in Medium 199 plus 10% FCS (modified from [171) .
Rosette Test .
￿
20 pl of the0.5%suspension of sensitized red cellswere added to 20 Wl of the test
cell suspension (3 x 108 cells/ml) in plastic tubes (Luckhan Ltd., LP2) . Tubes were centrifuged at
400g for 5 min at 4°C . EAC-rosettes were immediately resuspended by gentle pipetting with a
Pasteur pipette ; EA-rosettes were resuspended after 30 min at 0°C . A drop of suspension was
placed on a siliconized slide and overlayed with a siliconized coverslip . The edges ofthe coverslip
were sealed with wax . Each test was performed in triplicate and the percentage of rosettesPETER H. KRAMMER, LESLIE HUDSON, AND JONATHAN SPRENT
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determined (a minimum of 300 cells per preparation was counted) . A cell with more than four
adherent erythrocytes was regarded as arosette .
Each test included erythrocyte rosettes (E-rosettes) as simultaneous controls for EA(IgG)-
rosettes and EA(IgM)-rosettes as controls for EAC-rosettes . Fluorochromasia with fluorescein
diacetate (FDA) (18) was used to assess the percentage of live cells forming rosettes .
Inhibition of Fc-Rosettes .
￿
Purified myeloma proteins (gifts from Drs.G. Torrigiani, R. Pink,
and F. Melchers), at a final concentration of 500 Wg/ml, were used to inhibit rosette formationand
were added to the cells at the same time as the IgG coated ORBC .
Results
FcR and C-Receptors onNormalLymphocyte Populations . Table I shows the
proportion of Fe- and C-receptor positive lymphocytes in various cell prepara-
tions . It is evidentthat ORBC coupled with either MIgG or RIgG [EA(IgG)lgave
roughly the same number of rosettes (Fc- and C-rosettes) at optimal dilution of
the antiserum . Rosettes were not detected with ORBC coated with
IgM[EA(IgM)] .
The proportion of cells forming Fc-rosettes found in thymus, lymph node,
spleen, and TDL agrees with other reports (1). The proportion ofFcR positive
cells was very low (1%) in normal thymus and in lymph node cells depleted ofB
cells by anti-Ig column filtration (<1% B cells by indirect immunofluorescence)
(Table I) .
A variety of T-cell enriched populations were tested for their capacity to form
Fc-rosettes [EA(IgG) or EA(IgM)] . Theseincluded : thymus cells stimulated with
either Con A or PHA, CRT, and CRT stimulated with Con A or PHA. Within
each of these populations only a few (<1%) formed Fc-rosettes [EA(IgG)] (data
not shown) . It is important to emphasize that these experiments were always
TABLE I
FcR and C-Receptors on Normal Lymphocyte Populations
ND, not determined ; Results are expressed as mean andrange of at least two experiments.
' CBA/J cells (a pool from at least two mice) were used for cell preparation .
t 3.5% of CRT Ig positive by direct immunofluorescence .
§ Anti-Ig column modified from Schlossmannand Hudson (8) .
11 Ig positive cells by indirect immunofluorescence <1% .
4 TDLwere prepared as described by Sprent (6) .
" No difference in numbers of rosettes with three or nine washes before rosette formation .
Cell population' E EA(IgG)
MIgG RIgG
Rosettes
MIgM
(range)
EA(IgM)
RIgM
EAC(MC)
MIgM RIgM
Thymus cells 0 0.75(0.6-1 .6) ND ND ND ND ND
CRT 0 3.5(3-4) ND ND ND ND ND
Lymph node cells 0 17(7-23) 20(10-28) 0 0 18(16-20) 17(13-19)
Lymph node cells 0 1.5(1-2) 1.5(1-2) 0 0 2(2-3) 1.8(1.3-2.3)
anti-Ig column ef-
fluent popula-
tion§
Spleen cells 0 41(40-42) 42(40-44) 0 0 ND ND
TDM ," 0 14(12-16) ND ND ND ND ND1406
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run in parallel with tests on normal spleen and lymph node cells as positive
controls ; the percentage ofFc-rosettes in each positive control was comparable to
the data shown in Table I .
FcR on Activated T Cells . 40% of activated T cells from the spleen of
irradiated F, mice (ATC-spleen) given H-2 orM-locus incompatible thymus cells
4 or 5 days previously formed Fc-rosettes (Table II) . More than 90% of the ATC-
spleen suspensions were viable after dead cell removal ; in addition >95% of
these viable cells were lysed by anti-Thy 1 .2 serum plus C . Only 1-2% of ATC-
spleen, however, formed EAC-rosettes (Table II) .
In another series of experiments, nylon-wool-purified T cells (Ig+ 0%, Thy 1 .2+
> 99%) derived from lymph nodes were used to prepare ATC-spleen . As seen in
Table III lymph node T cells, though FcR-negative before transfer (Table I),
developed FcR after in vivo activation by H-2- or M-locus differences . In both
populations, 80-90% of the Fc-rosette-forming cells were blasts . Again, the
number of EAC-rosettes was negligible .
95% of the M-locus-activated ATC-spleen (M-ATC-spleen) were lysed by anti-
Thy 1.2 serum and C . This serum lysed 100% of H-2-ATC-spleen (Fig . 1) ; by
indirect immunofluorescence, 100% of these cells expressed Thy 1.2, and 0%
were Ig+ . Fig . 1 also shows that virtually all of the isolated H-2-ATC-spleen
were donor-derived, i .e . 100% of the cells were killed with C57BL anti-CBA
serum, whereas only background lysis was obtained with CBA anti-C57BL
(antihost) serum ; the latter killed almost 100% of normal C57BL or (CBA x
C57BL)F, cells .
Inhibition ofATC FcR by Purified Myeloma Proteins .
￿
The degree of inhibi-
tion of Fc-rosette formation by purified myeloma proteins is shown inTable IV .
At the protein concentration used, only MOPC 141 (IgG2b) gave strong inhibi-
tion of rosette formation, using both M-ATC-spleen and H-2-ATC-spleen . No
inhibition was observed with either cellular or secreted IgM from MOPC 104 .
Failure to DetectFcR on T.TDL .
￿
Almost 100% ofT.TDL are Thy 1.2 positive
and of donor origin (Fig . 2) . In direct contrast to ATC-spleen, T.TDL contained
TABLE II
FcR and C-Receptor on Activated T Cells Prepared by Injection ofThymus Cells into
Irradiated H-2- or M-Locus Different Hosts
% Rosettes (range)§
' H-2-ATC-spleen collected 5 days andM-ATC-spleen 4 days after thymocyte transfer .
# Both cell populations were >95% T cells by cytotoxicity test with anti-Thy 1.2 serumand GPC.
§ Numbers are expressed as mean and range of two experiments .
11 Mean t SE .
9 2 x 108 CBAthymocytes injected i.v . into 800Rirradiated (CBA/J x C57BL)F, mice .
" 2 x 108 C3H thymocytes injected i.v . into 800 R irradiated CBA/Jmice .
## More than 50% of EA-rosettes were blast cells .
% Ig
positive
cells1l
ND
Activated' T cells*
(spleen)
E
MIgG
EA(IgG)
RIgG MIgG
EA(IgM)
RIgM Might
EAC(MC)
RIgM
Activation by H-2 0 37(32-48) 44(43-48) 0 0 1(0-3) 2(1-4)
difference4
Activation by M-lo- 0 15(13- 11(6-16)## 0 0 ND ND
cus difference" 17)##PETER H . KRAMMER, LESLIE HUDSON, AND JONATHAN SPRENT
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TABLE III
Fc- and C-Receptors on Activated T Cells Prepared by Injection ofNylon Wool Purified
Lymph Node T Cells into Irradiated H-2- or M-Locus Different Hosts
Activated T cells
(spleen)
Activation by H-2-dif-
￿
(CBA/J x C57BL)F,
￿
CBA/J§
￿
0
￿
27(25-29) 11
￿
0
￿
0.5(0-1)
ference#
Activation by M-lo- CBA/J
￿
C3H/J§
￿
0 15(14-16)**
￿
0
￿
0
cus differenceT
* 5 x 108 viable nylon wool purified T cells injected i.v .
# 5-day activation ; pool of three mice ; Ig' 0%, 100% Thy 1.2 positive by indirect immunofluores-
cence (200 cells counted per preparation) . See also Fig. 1 .
§ Ig positive : 0%, Thy 1.2 positive : >99% (200 cells counted per preparation) .
1188% of the rosetting cells were blast cells (200 rosettes counted) .
4 4-day activation ; pool of fourmice; more than 95%T cells by cytotoxicity with anti-Thy 1.2 serum
and RC .
** 78% of the rosetting cells were blast cells (200 rosettes counted) .
FIG. 1 . Percent lysis of CBA/J H-2-ATC-spleen (derived from X-irradiated (CBA/J x
C57BL)F, hybrid mice given nylon wool column purified CBA/J lymph node T cells) by
various antisera plus complement . Hatched bars represent controls with cells alone, cells
and complement, and cells and antiserum alone .
Donor
(nylon % Rosettes (range) on activated T
wool cells (spleen)
Irradiated recipient purified
lymph E EA EA EAC
node (MIgG) (MIgM) (MIgM,
cells)* MC)1408
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TABLE IV
Inhibition ofFc-Rosettes with H-2-ATC-Spleen and M-ATC-Spleen by Purified
Myeloma Proteins
* Purified myeloma proteins at final concentration of 500 Wg/ml .
t Myeloma proteins were added to the lymphocytes at the same time as the IgG-coated ORBC .
Inhibition calculated fromthemean percent ofrosettes without addition of myeloma proteins .
§ Same cell populations as in Table III .
FIG. 2 .
￿
Percent lysis of CBA/J H-2-T.TDL (derived from X-irradiated (CBA/J x C57BL)F,
hybrid mice given CBA/J lymph node cells) by various antisera and rabbit complement .
Controls as in Fig . 1 .
no Fc-rosette-forming cells (Table V), using ORBC coated with MIgG, RIgG,
MIgM, or RIgM . EAC-(MIgM, RIgM, MC) rosettes were also absent .
No rosette-forming cells were detected when T.TDL were incubated with
ORBC AT 37°C instead of at4°C or iftheT.TDL were preincubated at 37°C for 6-
8h in RPMI 199 and 10% FCS (5% CO2 incubator) .
A high proportion of T.TDL raised against H-2 differences (H-2-T.TDL) ex-
press surface Ig (Table V) most ofwhich appears to be specific IgM antibody of
donor B-cell origin (19) . To determine whether the presence of this material
Myeloma Ig class*
% Inhibition
H-2-ATC-
spleen§
of Fe-rosettes$
M-ATC-
spleen§
MOPC 104 Secreted IgM 9 13
MOPC 104 Cellular IgM 0 0
MOPC 315 IgA 0 7
RPC 23 IgGl 0 0
SS 63 IgG2a 2 3
MOPC 141 IgG2b 81 83PETER H. KRAMMER, LESLIE HUDSON, AND JONATHAN SPRENT
TABLE V
Assay for Fc and C-Receptors and Ig on T.TDL
difference"
' Cells collected from thoracic duct lymph at 4 to 5 days after thymocyte transfer.
t Data derived from three experiments.
§ Mean ± SE.
~~ 2 x 108 CBA/J thymocytes injected i.v, into 800R irradiated (CBA/J-C57BL)F, mice.
1f Thymocytes were B-cell depleted by filtration through anti-Ig columns.
"' 2 x 108 C3H thymocytes injected i.v. into 800R irradiated CBA/J mice.
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could have contributed to the failure of T. TDL to form Fc-rosettes, tests 'were
carried out with two populations of T.TDL which lack surface Ig. These popula-
tions were (a) H-2-T.TDL prepared from T cells depleted of B cells before
injection and (b) T.TDL raised between strains differing by determinants recog-
nized by T cells but not B cells, i.e., M-locus determinants (M-T.TDL) . As shown
in Table V, neither of these populations formed Fc-rosettes.
Previous work' showed that when T.TDL were reexposed to the activating
antigens, i.e . by transfer to secondary hosts syngeneic with the primary hosts,
the cells synthesized DNA in the spleens of their new hosts. Irradiated Fi mice
receiving H-2-T.TDL had twice as many Fc-rosette-forming cells per spleen
compared to unreconstituted X-irradiated mice (Table VI). This would suggest
that at least a proportion of T.TDL had the potential to express FeR after
reactivation.
Ia-Antigens on ATC. Ia-antigens can easily be demonstrated on B cells
where they are closely associated with the B cell FcR (20). In agreement with
other authors (10), Is antigens were demonstrated in a microcytotoxicity assay
with ATH anti-ATL serum and C on a low number of thymus cells and a
proportion of cortisone resistant and lymph node T cells (Fig. 3).
Fig. 1 and 4 show that la-antigens were also expressed on H-2-activated T cells
(ATC-spleen and H-2-T.TDL). As ATH anti-ATL serum is specific for Iak deter-
minants, i.e. determinants present on cells from H-2 k (e.g. CBA/J) strains but
not on H-25 (e.g. SJL/J) strains, the antiserum lysed only H-2-ATC-spleen of
CBA/J origin (Fig. 1), but not of SJL/J origin (Fig. 4). Virtually all H-2-ATC of
s Sprent, J. 1975. Recirculating lymphocytes. In The Lymphocyte Structure and Function. J. J.
Marchalonis, editor. Marcel Dekker, Inc ., New York. Manuscript in preparation,
% Rosettes#
Ig
T.TDL" E EA(IgG) EA(IgM) EAC(MC) positive
MIgG RIgG MIgM RIgM MIgM RIgM
cells§
Activation by H-2-differ- 0 0 0 0 0 0 0 67 ± 6
ence 11
Activation of B-depleted 0 0 0 0 0 0 0 9 ± 1
thymocytes by H-2-dif-
ference$
Activation by M-locus 0 0 ND 0 ND ND ND 2 ± 0.51410 Fe-RECEPTORS, la-ANTIGENS, AND Ig ON T LYMPHOCYTES
TABLE VI
Assay for Fc-Receptors on T.TDL Reinjected into Secondary, Irradiated Recipients
Cells tested'
CBA/J mice given no cells (D)
Total number of
EA(MIgG)-rosettes per
spleen
Ratio of total numbers
of EA(MIgG)-rosettes
between cell popula-
tions A, B and C, D
" Spleen cells taken 2 days after injection ofT.TDL .
# T.TDL activated by H-2- andM-locus difference as in TableV. 5 x 108 ofT.TDL transferred into
secondary recipients within 2 h of irradiation of the recipient mice .
§ Data in table from a single experiment and one mouse in each group . Four other experiments
gave similar results (range of ratios 1.7-2.1 (4) and 1.3-2.6 [51) .
FIG. 3.
￿
Percent lysis of thymus, cortisone resistantthymus, and lymph node cells(CBA)
by ATH anti-ATL serum . Assay conditions as in Fig . 1 .
SJL origin were killed by anti-Thy 1 .2 serum as well as by C57 anti-SJL serum.
The titer of the anti-la serum on CBA H-2-ATC (spleen and TTDL), however,
wasmuch lower than on CBA normal spleen cells (10) .
Discussion
In using antibody-coated erythrocytes for detecting FcR, selected samples of
ORBC have the advantage that, unlike sheep RBC, they do not agglutinate
Spleen cells from X-irradiated (800 R) 116 x 10°
(CBA/J x C57BL)F, mice injected with
C57BL-activated CBA/J T.TDLt (A) A
=2§
B
Spleen cells from X-irradiated (800 R) 58 x 10 4
(CBA/J x C57BL)F, mice given no cells
(B)
Spleen cells from X-irradiated (800 R) CBA/ 140 x 10°
J mice injected with CBA/J-activated
C3H/J T.TDL# (C)
C =2.6§
D
Spleen cells from X-irradiated (800 R) 54 x 10"PETER H . KRAMMER, LESLIE HUDSON, AND JONATHAN SPRENT
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FIG . 4 . Percent lysis of SJL/J H-2-ATC spleen (derived from X-irradiated (SJL/J x
C57BL)F, hybrid mice given SJL/J nylon wool column purified lymph node T cells) by
various antisera . Conditions as in Fig . 1 .
when treated with high concentrations of antierythrocyte antibody (23) . Anti-
body-coated ORBC should therefore present a greater density of Fc-determi-
nants to FcR-bearing cells. Thus, antibody-coated ORBC are sensitive indicator
cells for detecting FcR. Furthermore, preference for the ORBC rosetting tech-
nique is based on the ease with which a fractionation of rosetting and nonroset-
ting cells can eventually be accomplished .
FcR were detected on 20% of normal lymph node cells, but not on normal
cortisone-resistant thymus cells or on lymph node cells depleted of Ig-bearing
cells . These data are consistent with the evidence of other workers that the
majority ofB lymphocytes, but not T lymphocytes, express easily detectable FcR
(1 ).
Of the various T-cell populations studied, FcR were detected only on ATC-
spleen . As with B cells, rosette formation with ATC-spleen was demonstrable
with EA(IgG), butnotwith EA(IgM); furthermore, as observed by other workers
(2), rosette formation was blocked in the presence of myeloma IgG (IgG2b) but
not with IgM. In contrast to B cells, ATC-spleen did not express detectable C-
receptors . Significantly, FcR were not detected on other activated T-cell popula-
tions, i.e .,T.TDL, ConA blasts, or PHA blasts . H-2-T.TDL derivedfrom normal
thymus or lymph node cellscarry surface IgM which appears to be donor-B-cell-
derived alloantibody (19) . It was possible, therefore, that the failure to detect
FcR on T.TDL was the result of blockade by passively absorbed surface Ig . This
seemed unlikely, however, since FcR were also not detectable on two popula-
tions of T.TDL which lacked surface Ig : (a) H-2-T.TDL derived from T-cell
populations depleted of B cells and (b) T.TDL raised against M-locus determi-
nants, i.e ., determinants which stimulate T cells but do notinduce alloantibody
formation by B cells (22) (Table VII) .
Inasmuch as the production of T.TDL is associated with extensive T-cell
proliferation in the lymphoid organs, particularly the spleen (23), it is probable
that T.TDL are largely derived from ATC-spleen . The present data might
suggest, therefore, that in response to major transplantation antigens or M-
locus determinants in vivo, T cells change from being FcR-negative at the time
of injection to FcR-positive during proliferation in the spleen and then revert to
an FcR-negative state during migration into the central lymph . Can one con-141 2 Fc-RECEPTORS, Ia-ANTIGENS, AND Ig ON T LYMPHOCYTES
TABLE VII
Summary ofResults.Immunoglobulin, Fc-Receptors, andIa-Antigens on theMembrane
of Various T-Cell Populations
clude, therefore, that T cells express FcR only at a precise stage of differentia-
tion? Several points are of relevance to this question.
(a) It has been mentioned that most T.TDL are probably derived from ATC-
spleen. There is no evidence, however, that the progenitors in the spleen are
FcR-positive. Since the proportion of FcR-positive cells in ATC-spleen did not
exceed 50%, it is equally possible that T.TDL were derived from the FcR-
negative population. It is nevertheless of interest that T .TDL appeared to
express FcR when they were restimulated upon secondary transfer (Table VI).
(b) Since FcR were not demonstrable on T cells stimulated with PHA or Con
A, the expression of FcR did not appear to be simply a nonspecific event upon
blast transformation.
(c) The rosetting technique is only one of several techniques available for
detecting FeR. In this respect it is reported that FcR can be demonstrated with
heat-aggregated Ig on normal thymus cells (2) . It could be argued, therefore,
that the failure to find FcR on T.TDL reflected inadequacies in the sensitivity or
the specificity of the technique employed. On this point it may be mentioned
that in a separate study, Basten et al.4 have been unable to demonstrate FcR on
T.TDL with a variety of techniques, viz. rosetting with SRBC, heat-aggregated
human gamma globulin, and radiolabeled immune complexes. Despite these and
our negative findings, Ig can be detected on a large proportion of H-2-T.TDL
(Table V and (19)), but not on H-2-ATC-spleen (Table II). These findings will be
discussed in detail elsewhere.s
In view of the above points it is equally possible that there is no clear-cut
division of T cells into FcR-positive and FcR-negative cells, but that at certain
stages of differentiation there is either a quantitative or qualitative change in
the expression of these receptors.
No evidence was found that IgM was cytophilic for either T cells or B cells.
Nevertheless, uptake of IgM has been demonstrated on T cells by a variety of
techniques and in several species, e .g. rats (24), chickens (25), and man (26) .
" Basten, A., J. F. A. P. Miller, N. L. Warner, R. Abraham, E. Chico, and J. Gamble. 1975.
A subpopulation of T cells bearing Fc receptors. J. Immunol. 115:1159.
' Hudson,L., and J. Sprent. 1975. The specific adsorption of IgMantibody onto activatedmouse
T lymphocytes. Manuscript in preparation.
Cell population % Ig positive %Fc-receptorpos-
itive % la positive
Thymocytes 0.9 0.75 10
Cortisone resistant thymocytes 3.5 3.5 25
H-2-ATC-spleen 4.1 44 75
H-2-T.TDL 67 0 60
M-ATC-spleen ND* 15 ND
M-T.TDL 2 0 ND
* ND, not determined.PETER H. KRAMMER, LESLIE HUDSON, AND JONATHAN SPRENT
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Although in some of these studies it is not clear that the IgM detected was
indeed Fc-bound, it is possible nevertheless that T cells do have a limited
capacity to absorb IgM via FeR.
In view ofthe evidence of Dickler and Sachs(20) that FeR on B cells are closely
associated with Ia-antigens, the expression of these antigens was studied on
various FcR-positive and FcR-negative T cells. In agreement with other authors
(10) Ia-antigens were demonstrated on a proportion of CRT and lymph node T
cells. In addition it was observed that 80% of H-2-ATC-spleen and 60% of H-2-
T.TDL were Ia-positive.
It has been shown that several anti-Ia sera contain strong activity against C-
type viruses.s It is also known that such viruses can be activated by graft-vs.-
host reactions (27) . It was conceivable, therefore, that the lytic activity of the
anti-Ia serum on ATC (i.e., cells proliferating as the result of a graft vs . host
reaction) was directed against viral antigens. The fact that the antiserum used
(ATH anti-ATL (anti-Ia')) lysed CBA/JATC (Ia') but not SJL/J ATC (Ia') makes
this possibility unlikely. Experiments are currently in progress to exclude the
possibility that the la-antigens were passively absorbed.
In conclusion, the distribution of Ia-antigens, FcR, and Ig on the various T-
cell populations studied, as shown in Table VII, does not provide any evidence
for a discernible interrelationship between these three cell surface structures.
For Ia-antigens and FcR, however, biochemical studies on the molecular level
are necessary to determine an association of these cell surface components,
especially when they are present on the membrane of the same cell like on H-2-
ATC-spleen.
Summary
Using antibody coated bovine erythrocytes we were unable to demonstrate Fc-
receptors on either thymus cells or T cells prepared from lymph node cell
suspensions by anti-Ig column filtration. However, if parental thymus or lymh
node T cells were transferred to X-irradiated F, hybrids, activated donor T cells
recovered from the recipient's spleen (ATC-spleen) were shown to express Fc-
receptors. Fc-receptors were also demonstrable on ATC-spleen prepared be-
tween strain combinations differing at the M-locus. In marked contrast, Fc-
receptors were not detected on ATC recovered from thoracic duct lymph
(T.TDL). This applied to (a) H-2-activated T.TDL derived from normal thymus
cells, (b) H-2-activatedT.TDL derived from thymus cells depleted of B cells, and
(c) M-locus-activated T.TDL. Of these three populations, surface Ig (of B cell
origin) was detected on a large proportion of the first but not on the second and
third populations. Thus, the failure to detect Fc-receptors on any of these
populations could not be attributed to blocking by adsorbed surface Ig.
In addition, various T-cell populations were examined by a microcytotoxicity
assay forthe presence of cell surface Ia-antigens. 5-10% of the thymus cells, 20-
30% ofcortisone-resistant thymus cells, 60-70% of lymph node cells, and60-80%
of ATC-spleen and T.TDL showed Ia.
s Wettstein, P. J., P. H. Krammer, C. S. David, J. A. Frelinger, and D. C. Shreffler. 1975. A
cautionary note regarding Ia and H-2 typing ofmurine lymphoid tumors. Manuscript in prepara-
tion.1414
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